Denosumab

Tax included
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures, also has anti-cancer activity.
MedChemExpress 
HY-P9958

Data sheet

Size
Multiple sizes
Reactivity
NF-κB
Application
Cancer-programmed cell death
CAS
615258-40-7